Advertisement
Screener

Pacific Biosciences of California, Inc. (PACB) Comprehensive Income

2.8 / 5 stars · 68/120 Roast Me

Pacific Biosciences of California, Inc. Comprehensive Income

Pacific Biosciences of California, Inc. (PACB) reported Comprehensive Income of -$45.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06

  • Pacific Biosciences of California, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$45.10M.
  • Pacific Biosciences of California, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$8.88M.
  • Pacific Biosciences of California, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$40.33M, a 3352.34% decline year-over-year.
  • Pacific Biosciences of California, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$37.85M.
  • Pacific Biosciences of California, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$546.34M.
  • Pacific Biosciences of California, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$309.65M.
  • Pacific Biosciences of California, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$301.75M.
  • Pacific Biosciences of California, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$317.93M.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month
2026-06-30-$45.10M
10-Q · filed 2026-08-06
-$53.98M
10-Q · filed 2026-08-06
-$94.31M
derived: sum of 3 quarters · filed 2026-08-06
-$132.16M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$8.88M
10-Q · filed 2026-05-08
-$49.21M
derived: sum of 2 quarters · filed 2026-05-08
-$87.06M
derived: sum of 3 quarters · filed 2026-05-08
-$129.10M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$40.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
-$78.18M
derived: sum of 2 quarters · filed 2026-02-25
-$120.22M
derived: sum of 3 quarters · filed 2026-08-06
-$546.34M
10-K · filed 2026-02-25
2025-09-30-$37.85M
10-Q · filed 2025-11-06
-$79.90M
derived: sum of 2 quarters · filed 2026-08-06
-$506.01M
10-Q · filed 2025-11-06
-$504.77M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$42.04M
10-Q · filed 2026-08-06
-$468.16M
10-Q · filed 2026-08-06
-$466.92M
derived: sum of 3 quarters · filed 2026-08-06
-$525.57M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$426.12M
10-Q · filed 2026-05-08
-$424.88M
derived: sum of 2 quarters · filed 2026-05-08
-$483.52M
derived: sum of 3 quarters · filed 2026-05-08
-$657.06M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$1.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
-$57.41M
derived: sum of 2 quarters · filed 2026-02-25
-$230.94M
derived: sum of 3 quarters · filed 2026-02-25
-$309.65M
10-K · filed 2026-02-25
2024-09-30-$58.65M
10-Q · filed 2025-11-06
-$232.19M
derived: sum of 2 quarters · filed 2025-11-06
-$310.89M
10-Q · filed 2025-11-06
-$390.85M
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30-$173.54M
10-Q · filed 2025-08-07
-$252.24M
10-Q · filed 2025-08-07
-$332.20M
derived: sum of 3 quarters · filed 2026-02-25
-$398.22M
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31-$78.70M
10-Q · filed 2025-05-12
-$158.66M
derived: sum of 2 quarters · filed 2026-02-25
-$224.69M
derived: sum of 3 quarters · filed 2026-02-25
-$295.28M
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31-$79.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
-$145.98M
derived: sum of 2 quarters · filed 2026-02-25
-$216.58M
derived: sum of 3 quarters · filed 2026-02-25
-$301.75M
10-K · filed 2026-02-25
2023-09-30-$66.02M
10-Q · filed 2024-11-12
-$136.62M
derived: sum of 2 quarters · filed 2024-11-12
-$221.79M
10-Q · filed 2024-11-12
-$304.68M
derived: sum of 4 quarters · filed 2025-03-17
2023-06-30-$70.59M
10-Q · filed 2024-08-09
-$155.77M
10-Q · filed 2024-08-09
-$238.66M
derived: sum of 3 quarters · filed 2025-03-17
-$316.43M
derived: sum of 4 quarters · filed 2025-03-17
2023-03-31-$85.17M
10-Q · filed 2024-05-09
-$168.06M
derived: sum of 2 quarters · filed 2025-03-17
-$245.84M
derived: sum of 3 quarters · filed 2025-03-17
-$318.60M
derived: sum of 4 quarters · filed 2025-03-17
2022-12-31-$82.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17
-$160.66M
derived: sum of 2 quarters · filed 2025-03-17
-$233.43M
derived: sum of 3 quarters · filed 2025-03-17
-$317.93M
10-K · filed 2025-03-17
2022-09-30-$77.77M
10-Q · filed 2023-11-03
-$150.54M
derived: sum of 2 quarters · filed 2023-11-03
-$235.04M
10-Q · filed 2023-11-03
-$305.48M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30-$72.77M
10-Q · filed 2023-08-04
-$157.26M
10-Q · filed 2023-08-04
-$227.71M
derived: sum of 3 quarters · filed 2024-02-28
-$211.13M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31-$84.50M
10-Q · filed 2023-05-04
-$154.94M
derived: sum of 2 quarters · filed 2024-02-28
-$138.37M
derived: sum of 3 quarters · filed 2024-02-28
-$179.45M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31-$70.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
-$53.87M
derived: sum of 2 quarters · filed 2024-02-28
-$94.95M
derived: sum of 3 quarters · filed 2024-02-28
-$182.40M
10-K · filed 2024-02-28
2021-09-30$16.57M
10-Q · filed 2022-11-08
-$24.51M
derived: sum of 2 quarters · filed 2022-11-08
-$111.95M
10-Q · filed 2022-11-08
-$37.05M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30-$41.08M
10-Q · filed 2022-08-08
-$128.53M
10-Q · filed 2022-08-08
-$53.63M
derived: sum of 3 quarters · filed 2023-02-28
-$77.46M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$87.45M
10-Q · filed 2022-05-06
-$12.54M
derived: sum of 2 quarters · filed 2023-02-28
-$36.38M
derived: sum of 3 quarters · filed 2023-02-28
-$59.25M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$74.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$51.07M
derived: sum of 2 quarters · filed 2023-02-28
$28.20M
derived: sum of 3 quarters · filed 2023-02-28
$29.48M
10-K · filed 2023-02-28
2020-09-30-$23.83M
10-Q · filed 2021-11-05
-$46.71M
derived: sum of 2 quarters · filed 2021-11-05
-$45.42M
10-Q · filed 2021-11-05
-$45.52M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30-$22.87M
10-Q · filed 2021-08-06
-$21.59M
10-Q · filed 2021-08-06
-$21.68M
derived: sum of 3 quarters · filed 2022-02-28
-$50.81M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$1.29M
10-Q · filed 2021-05-06
$1.19M
derived: sum of 2 quarters · filed 2022-02-28
-$27.94M
derived: sum of 3 quarters · filed 2022-02-28
-$52.52M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31-$97.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
-$29.23M
derived: sum of 2 quarters · filed 2022-02-28
-$53.81M
derived: sum of 3 quarters · filed 2022-02-28
-$84.09M
10-K · filed 2022-02-28
2019-09-30-$29.13M
10-Q · filed 2020-11-03
-$53.71M
derived: sum of 2 quarters · filed 2020-11-03
-$84.00M
10-Q · filed 2020-11-03
-$114.81M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30-$24.59M
10-Q · filed 2020-08-06
-$54.87M
10-Q · filed 2020-08-06
-$85.68M
derived: sum of 3 quarters · filed 2021-02-26
-$110.73M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31-$30.28M
10-Q · filed 2020-05-08
-$61.09M
derived: sum of 2 quarters · filed 2021-02-26
-$86.14M
derived: sum of 3 quarters · filed 2021-02-26
-$108.66M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31-$30.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
-$55.86M
derived: sum of 2 quarters · filed 2021-02-26
-$78.38M
derived: sum of 3 quarters · filed 2021-02-26
-$102.57M
10-K · filed 2021-02-26
2018-09-30-$25.05M
10-Q · filed 2019-11-07
-$47.57M
derived: sum of 2 quarters · filed 2019-11-07
-$71.75M
10-Q · filed 2019-11-07
-$92.55M
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30-$22.52M
10-Q · filed 2019-08-06
-$46.70M
10-Q · filed 2019-08-06
-$67.50M
derived: sum of 3 quarters · filed 2020-02-28
-$89.50M
derived: sum of 4 quarters · filed 2020-02-28
2018-03-31-$24.18M
10-Q · filed 2019-05-03
-$44.98M
derived: sum of 2 quarters · filed 2020-02-28
-$66.98M
derived: sum of 3 quarters · filed 2020-02-28
-$92.54M
derived: sum of 4 quarters · filed 2020-02-28
2017-12-31-$20.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
-$42.80M
derived: sum of 2 quarters · filed 2020-02-28
-$68.35M
derived: sum of 3 quarters · filed 2020-02-28
-$92.23M
10-K · filed 2020-02-28
2017-09-30-$22.01M
10-Q · filed 2018-11-05
-$47.56M
derived: sum of 2 quarters · filed 2018-11-05
-$71.43M
10-Q · filed 2018-11-05
-$90.48M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30-$25.55M
10-Q · filed 2018-08-03
-$49.43M
10-Q · filed 2018-08-03
-$68.47M
derived: sum of 3 quarters · filed 2019-02-26
-$86.00M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31-$23.88M
10-Q · filed 2018-05-02
-$42.92M
derived: sum of 2 quarters · filed 2019-02-26
-$60.45M
derived: sum of 3 quarters · filed 2019-02-26
-$78.93M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31-$19.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
-$36.57M
derived: sum of 2 quarters · filed 2019-02-26
-$55.06M
derived: sum of 3 quarters · filed 2019-02-26
-$74.36M
10-K · filed 2019-02-26
2016-09-30-$17.52M
10-Q · filed 2017-11-02
-$36.01M
derived: sum of 2 quarters · filed 2017-11-02
-$55.31M
10-Q · filed 2017-11-02
-$56.74M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30-$18.49M
10-Q · filed 2017-08-02
-$37.79M
10-Q · filed 2017-08-02
-$39.21M
derived: sum of 3 quarters · filed 2018-02-26
-$37.40M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31-$19.30M
10-Q · filed 2017-05-05
-$20.73M
derived: sum of 2 quarters · filed 2018-02-26
-$18.91M
derived: sum of 3 quarters · filed 2018-02-26
-$30.85M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31-$1.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$393.00K
derived: sum of 2 quarters · filed 2018-02-26
-$11.55M
derived: sum of 3 quarters · filed 2018-02-26
-$31.71M
10-K · filed 2018-02-26
2015-09-30$1.81M
10-Q · filed 2016-11-04
-$10.12M
derived: sum of 2 quarters · filed 2016-11-04
-$30.29M
10-Q · filed 2016-11-04
-$49.28M
derived: sum of 4 quarters · filed 2017-03-06
2015-06-30-$11.94M
10-Q · filed 2016-08-04
-$32.10M
10-Q · filed 2016-08-04
-$51.09M
derived: sum of 3 quarters · filed 2017-03-06
-$60.28M
derived: sum of 4 quarters · filed 2017-03-06
2015-03-31-$20.17M
10-Q · filed 2016-05-05
-$39.16M
derived: sum of 2 quarters · filed 2017-03-06
-$48.34M
derived: sum of 3 quarters · filed 2017-03-06
-$67.45M
derived: sum of 4 quarters · filed 2017-03-06
2014-12-31-$18.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06
-$28.17M
derived: sum of 2 quarters · filed 2017-03-06
-$47.28M
derived: sum of 3 quarters · filed 2017-03-06
-$66.17M
10-K · filed 2017-03-06
2014-09-30-$9.18M
10-Q · filed 2015-11-05
-$28.29M
derived: sum of 2 quarters · filed 2015-11-05
-$47.18M
10-Q · filed 2015-11-05
-$64.40M
derived: sum of 4 quarters · filed 2016-03-11
2014-06-30-$19.11M
10-Q · filed 2015-08-05
-$37.99M
10-Q · filed 2015-08-05
-$55.22M
derived: sum of 3 quarters · filed 2016-03-11
-$75.70M
derived: sum of 4 quarters · filed 2016-03-11
2014-03-31-$18.88M
10-Q · filed 2015-05-05
-$36.11M
derived: sum of 2 quarters · filed 2016-03-11
-$56.58M
derived: sum of 3 quarters · filed 2016-03-11
-$77.07M
derived: sum of 4 quarters · filed 2016-03-11
2013-12-31-$17.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
-$37.70M
derived: sum of 2 quarters · filed 2016-03-11
-$58.19M
derived: sum of 3 quarters · filed 2016-03-11
-$79.31M
10-K · filed 2016-03-11
2013-09-30-$20.47M
10-Q · filed 2014-11-05
-$40.96M
derived: sum of 2 quarters · filed 2014-11-05
-$62.08M
10-Q · filed 2014-11-05
-$83.79M
derived: sum of 4 quarters · filed 2015-03-12
2013-06-30-$20.48M
10-Q · filed 2014-08-05
-$41.61M
10-Q · filed 2014-08-05
-$63.31M
derived: sum of 3 quarters · filed 2015-03-12
-$86.05M
derived: sum of 4 quarters · filed 2015-03-12
2013-03-31-$21.12M
10-Q · filed 2014-05-08
-$42.83M
derived: sum of 2 quarters · filed 2015-03-12
-$65.57M
derived: sum of 3 quarters · filed 2015-03-12
-$88.11M
derived: sum of 4 quarters · filed 2015-03-12
2012-12-31-$21.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
-$44.44M
derived: sum of 2 quarters · filed 2015-03-12
-$66.99M
derived: sum of 3 quarters · filed 2015-03-12
-$94.49M
10-K · filed 2015-03-12
2012-09-30-$22.74M
10-Q · filed 2013-11-12
-$45.28M
derived: sum of 2 quarters · filed 2013-11-12
-$72.79M
10-Q · filed 2013-11-12
-$95.55M
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30-$22.55M
10-Q · filed 2013-08-09
-$50.05M
10-Q · filed 2013-08-09
-$72.81M
derived: sum of 3 quarters · filed 2014-03-14
-$102.28M
derived: sum of 4 quarters · filed 2014-03-14
2012-03-31-$27.50M
10-Q · filed 2013-05-10
-$50.26M
derived: sum of 2 quarters · filed 2014-03-14
-$79.73M
derived: sum of 3 quarters · filed 2014-03-14
-$102.03M
derived: sum of 4 quarters · filed 2014-03-14
2011-12-31-$22.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14
-$52.23M
derived: sum of 2 quarters · filed 2014-03-14
-$74.53M
derived: sum of 3 quarters · filed 2014-03-14
-$109.31M
10-K · filed 2014-03-14
2011-09-30-$29.47M
10-Q · filed 2012-11-01
-$51.76M
derived: sum of 2 quarters · filed 2012-11-01
-$86.55M
10-Q · filed 2012-11-01
2011-06-30-$22.30M
10-Q · filed 2012-08-07
-$57.08M
10-Q · filed 2012-08-07
2011-03-31-$34.78M
10-Q · filed 2012-05-07
2010-12-31-$140.19M
10-K · filed 2013-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B